High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytes

Human Gene Therapy

Volumn 14, Issue 4, 2003, Pages 385-391

  Rossi, Gabriela R ^a,c   Mautino, Mario R ^b,d   Morgan, Richard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Stoddard Cancer Research Institute   (United States)

^d Link Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; NITRIC OXIDE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; SPLEEN CELL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL LINE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; INTERLEUKIN-12; LENTIVIRUS; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PHAGOCYTOSIS; SPLEEN; TRANSDUCTION, GENETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE;

EID: 0037335185     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321208989     Document Type: Article

References (17)

1. AGARWAL, R.K., KANG, Y., ZAMBIDIS, E., SCOTT, D.W., CHAN, C.C., and CASPI, R.R. (2000). Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 106, 245-252.
2. CHINNASAMY, N., CHINNASAMY, D., TOSO, J.F., LAPOINTE, R., CANDOTTI, F., MORGAN, R.A., and HWU, P. (2000). Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum. Gene Ther. 11, 1901-1909.
3. GREWAL, I.S., and FLAVELL, R.A. (1998). CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135.
4. KANG, Y., MELO, M., DENG, E., TISCH, R., EL-AMINE, M., and SCOTT, D.W. (1999). Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: The IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc. Natl. Acad. Sci. U.S.A. 96, 8609-8614.
5. KAY, M.A., GLORIOSO, J.C., and NALDINI, L. (2001) Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7, 33-40.
6. LAGASSE, E., and WEISSMAN, I.L. (1996). Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197, 139-150.
7. LENSCHOW, D.J., WALUNAS, T.L., and BLUESTONE, J.A. (1996). CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
8. MACMICKING, J., XIE, Q.W., and NATHAN, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
9. METHAROM, P., ELLEM, K.A., SCHMIDT, C., and WEI, M.Q. (2001). Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Hum. Gene Ther. 12, 2203-2213.
10. MORDELET, E., KISSA, K., CALVO, C.F., LEBASTARD, M., MILON, G., VAN DER WERF, S., VIDAL, C., and CHARNEAU, P. (2002). Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: An approach to complement brain dysfunctions. Gene Ther. 9, 46-52.
11. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
12. NATHAN, C., and XIE, Q.W. (1994). Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725-13728.
13. PROPATO, A., CUTRONA, G., FRANCAVILLA, V., ULIVI, M., SCHIAFFELLA, E., LANDT, O., DUNBAR, CERUNDOLO, V., FERRARINI, M., and BARNABA, V. (2001). Apoptotic cells over-express vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat. Med. 7, 807-813.
14. ROSSI, G., SARKAR, J., and SCANDELLA, D. (2001). Long-term induction of immune tolerance after blockade of CD40-CD40L inter-action in a mouse model of hemophilia A. Blood 97, 2750-2757.
15. SCHULTZE, J.L., MICHALAK, S., LOWNE, J., WONG, A., GILLEECE, W.H., GRIBBEN, J.G., and NADLER, L.M. (1999). Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses. J. Exp. Med. 189, 1-12.
16. SCHULTZE, J.L., MICHALAK, S., SEAMON, M.J., DRANOFF, G., JUNG, K., DALEY, J., DELGADO, J.C., GRIBBEN, J.G., and NADLER, L.M. (1997). CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100, 2757-2765.
17. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.